Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dynavax
Pharma
FDA approves VBI's PreHevbrio just as HBV market is set to grow
With an FDA approval for its hepatitis B shot, PreHevbrio, VBI Vaccines is poised to take advantage of what figures to be a growing market.
Kevin Dunleavy
Dec 1, 2021 10:34am
Efficacy, convenient dosage give Dynavax's Heplisav-B an edge
Nov 5, 2021 7:00am
Clover, GSK part ways on COVID-19 vaccine
Feb 1, 2021 11:03am
Valneva inks production pact for COVID-19 vaccine adjuvant
Sep 16, 2020 10:12am
Sinopharm, Sinovac, Takeda and more—FiercePharmaAsia
Jun 19, 2020 10:44am
Remdesivir, Indian pharmas, CanSino and more—FiercePharmaAsia
Apr 17, 2020 10:48am
